Myelodysplastic syndromes (MDS) are preleukemic conditions involving clonal stem cell abnormalities, leading to ineffective blood cell production. Early detection and understanding clonal changes are crucial for managing this complex hematologic disorder.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: